Incorporating Biomarkers to Improve Statistical Power of Immunotherapeutic Neoadjuvant Clinical Trials in Patients with Triple-Negative Breast Cancer. (3rd July 2019)
- Record Type:
- Journal Article
- Title:
- Incorporating Biomarkers to Improve Statistical Power of Immunotherapeutic Neoadjuvant Clinical Trials in Patients with Triple-Negative Breast Cancer. (3rd July 2019)
- Main Title:
- Incorporating Biomarkers to Improve Statistical Power of Immunotherapeutic Neoadjuvant Clinical Trials in Patients with Triple-Negative Breast Cancer
- Authors:
- Gao, Feng
Wang, Guoqiao
Luo, Jingqin
Liu, Jingxia
Chen, Ling
Xiong, Chengjie - Abstract:
- Abstract: Neoadjuvant (preoperative) approach to breast cancer treatment has become widely accepted. Traditionally, the primary objective of neoadjuvant treatment is to improve subsequent surgical intervention and the effectiveness is often evaluated by its ability to achieve complete pathological response (pCR) and the eradication of the malignant disease in the breast and axillary lymph nodes. More recently, neoadjuvant treatment has also become recognized as an in vivo, preoperative" window of opportunity" to explore the efficacy of novel agents such as immunotherapies where several tumor biomarkers are also routinely collected to quantify antitumor immunity. However, one challenge to combine the traditional pCR and efficacy biomarkers is that these tumor biomarkers are only partially available and cannot be measured in patients who have achieved pCR. In this article, a stepwise hypothesis testing procedure is proposed to combine a continuous tumor biomarker with the conventional binary endpoint in a two-arm randomized phase II superiority trial to improve statistical power. The operating characteristics of the proposed procedure are illustrated with a real-world example and the performance is also evaluated numerically.
- Is Part Of:
- Statistics in biopharmaceutical research. Volume 11:Number 3(2019)
- Journal:
- Statistics in biopharmaceutical research
- Issue:
- Volume 11:Number 3(2019)
- Issue Display:
- Volume 11, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 11
- Issue:
- 3
- Issue Sort Value:
- 2019-0011-0003-0000
- Page Start:
- 210
- Page End:
- 219
- Publication Date:
- 2019-07-03
- Subjects:
- Cancer immunotherapy -- Immune biomarkers -- Multiple endpoints -- Multiple Hypotheses -- Neoadjuvant clinical trials
Pharmacy -- Statistical methods -- Periodicals
Pharmaceutical biotechnology -- Statistical methods -- Periodicals
Biopharmaceutics -- Periodicals
Biometry -- Periodicals
Pharmacy -- Statistical methods
Periodicals
615.190727 - Journal URLs:
- http://www.tandfonline.com/toc/usbr20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/19466315.2018.1518259 ↗
- Languages:
- English
- ISSNs:
- 1946-6315
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14199.xml